Failure of septal lesions to alter muscarinic cholinergic or benzodiazepine binding sites in hippocampus of rat brain.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004148:Dioxolanes / Q000378:metabolism; D005445:Flunitrazepam / Q000378:metabolism*; D006624:Hippocampus / Q000201:enzymology*; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000378:metabolism*; D012686:Septal Nuclei / Q000502:physiology*
D014151:Anti-Anxiety Agents; D004148:Dioxolanes; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D005445:Flunitrazepam; D011813:Quinuclidinyl Benzilate; D002795:Choline O-Acetyltransferase